Ultrasmall Renally Clearable Silica Nanoparticles Target Prostate Cancer

Although important advances have been achieved in the development of radiolabeled prostate-specific membrane antigen (PSMA)-targeting ligand constructs for both diagnosis and therapy of prostate cancer (PCa) over the past decade, challenges related to off-target effects and limited treatment respons...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:ACS Appl Mater Interfaces
Egile Nagusiak: Chen, Feng, Ma, Kai, Zhang, Li, Madajewski, Brian, Turker, Melik Z., Gallazzi, Fabio, Cruickshank, Kiara, Zhang, Xiuli, Jenjitranant, Pocharapong, Touijer, Karim A., Quinn, Thomas P., Zanzonico, Pat, Wiesner, Ulrich, Bradbury, Michelle S.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2019
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7199444/
https://ncbi.nlm.nih.gov/pubmed/31675204
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/acsami.9b15195
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak